Year in Review highlights key rheumatology literature from the past year. Drs. England & Davidson share insights from clinical and basic science research.

Webinar OverviewDate: December 9, 2025, 7:00-8:30 PM ETDesigned for clinicians, trainees, and healthcare professionals, this session delves into the nuanced, often overlooked aspects of rheumatologic care with a particular focus in lupus, connective tissue disorders, and complex autoimmunity. Discover expert tips, diagnostic shortcuts, and therapeutic strategies that can transform clinical practice. From subtle clinical signs to evidence-based management pearls, this session offers a treasure trove of practical wisdom drawn from real-world experience and cutting-edge research. Test linkTarget AudienceRheumatologists, rheumatology interprofessionals, physician assistants, primary care providers who care for patients with rheumatic disease, fellows-in-training, and residents.Registration is discounted for ACR/ARP members. If you are not a member, consider joining ACR/ARP.Learning ObjectivesUpon completion of this activity, participants should be able to:Discuss key diagnostic clues, hidden patterns, and apply expert insights ('pearls') to enhance the diagnosis and management of complex rheumatological conditionsDistinguish uncommon presentations for more accurate diagnosis and optimal treatment of rheumatic diseasesExplain useful rules and less well-known facts of rheumatic diseases, especially relevant to clinicians and traineesCE & MOC InformationCMEACCME Accreditation StatementThe American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.AMA Designation StatementThe American College of Rheumatology designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.CME credit must be claimed by February 9, 2026, at 11:59 PM ET.Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.Nature of Financial RelationshipsAll individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify detailsNone: Has no relevant financial relationship(s) with ineligible companies to disclose.All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. [insert link to disclosure document]Acknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewLearning ObjectivesUpon completion of this activity, participants should be able to: Perform a comprehensive history and physical examination for a new patient, including a detailed musculoskeletal examination, joint assessment, and joint injections  Perform a disease-focused history and physical examination for a follow-up patient, including musculoskeletal examination, joint assessment, and joint injections  Formulate an appropriate differential diagnosis  Order appropriate laboratory, radiographic examinations, and other diagnostic testing  Utilize and integrate results of laboratory, radiographic examinations, and other diagnostic testing into management plans under the supervision/collaboration of a rheumatologist  Recognize the impact of social determinants of health and health disparities on provision of care and disease self-management when providing healthcare to diverse communities and populations  Recognize skin manifestations in diverse patient populations/ skin of color  With appropriate supervision/collaboration, recognize and manage a number of rheumatic diseases in the adult rheumatology clinic setting Target AudienceAdvanced practice providers (APPs) including both nurse practitioners and physician assistants; fellows in training; and pharmacists who are new to rheumatology

See cutting-edge insights across basic and clinical science in recorded sessions from the 2025 premier international rheumatology meeting that took place in Chicago.

In this activity, you will gain insights into research, data use, payer issues, APP roles, and practice growth to enhance care, and streamline operations in your practice.

Learn how to recognize rheumatic diseases on skin of color. Hear from dermatologists with expertise in diseases in skin of color & systemic sclerosis & its mimics.

See the new lupus nephritis guideline based on a standardized protocol that prioritized relevant clinical questions about LN treatments and a literature review.

Hear advancements and challenges in the management of ANCA-associated vasculitis (AAV) including how to apply treatment guidelines to different clinical scenarios.

Watch lectures from a range of content in areas such as therapeutic developments, recent research findings, and scientific advances from the ACR’s State-of-the-Art Clinical Symposium (SOTA) 2025.